Cargando…

MDR Tuberculosis Treatment

Multidrug-resistant (MDR) tuberculosis (TB), resistant to isoniazid and rifampicin, continues to be one of the most important threats to controlling the TB epidemic. Over the last few years, there have been promising pharmacological advances in the paradigm of MDR TB treatment: new and repurposed dr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Espinosa-Pereiro, Juan, Sánchez-Montalvá, Adrian, Aznar, Maria Luisa, Espiau, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878254/ https://www.ncbi.nlm.nih.gov/pubmed/35208510 http://dx.doi.org/10.3390/medicina58020188

Ejemplares similares

Usefulness of FDG PET/CT in the management of tuberculosis
por: Sánchez-Montalvá, Adrián, et al.
Publicado: (2019)

MDR & XDR Tuberculosis
por: Kumar, Prahlad
Publicado: (2017)

Association Between Trypanosoma cruzi DNA in Peripheral Blood and Chronic Chagasic Cardiomyopathy: A Systematic Review
por: Bosch-Nicolau, Pau, et al.
Publicado: (2022)

A retrospective study on the influence of siblings’ relatedness in Bolivian patients with chronic Chagas disease
por: Espinosa-Pereiro, Juan, et al.
Publicado: (2019)

Comparison of characteristics and mortality in multidrug resistant (MDR) and non-MDR tuberculosis patients in China
por: Sun, Yanni, et al.
Publicado: (2015)

Evaluation of Two Different Strategies for Schistosomiasis Screening in High-Risk Groups in a Non-Endemic Setting
por: Roade, Luisa, et al.
Publicado: (2023)

Collaborative public–private initiatives targeting multidrug-resistant tuberculosis (MDR-TB) supported by the Lilly MDR-TB Partnership: experiences in 2012–2016
por: Shelby, Peter W, et al.
Publicado: (2017)

COVID-19 Clinical Profile in Latin American Migrants Living in Spain: Does the Geographical Origin Matter?
por: Sempere, Abiu, et al.
Publicado: (2021)

‘Z(S)-MDR-TB' versus ‘Z(R)-MDR-TB': improving treatment of MDR-TB by identifying pyrazinamide susceptibility
por: Zhang, Ying, et al.
Publicado: (2012)

Safety of Rifampicin at High Dose for Difficult-to-Treat Tuberculosis: Protocol for RIAlta Phase 2b/c Trial
por: Espinosa-Pereiro, Juan, et al.
Publicado: (2022)

The Rationale for Using Rifabutin in the Treatment of MDR and XDR Tuberculosis Outbreaks
por: Sirgel, Frederick A., et al.
Publicado: (2013)

Treatment outcomes of MDR-tuberculosis patients in Brazil: a retrospective cohort analysis
por: Bastos, Mayara Lisboa, et al.
Publicado: (2017)

Raltegravir does not revert efflux activity of MDR1-P-glycoprotein in human MDR cells
por: Dupuis, Maria Luisa, et al.
Publicado: (2013)

Transmission of MDR and XDR Tuberculosis in Shanghai, China
por: Zhao, Ming, et al.
Publicado: (2009)

Early appropriate diagnostics and treatment of MDR Gram-negative infections
por: Bassetti, Matteo, et al.
Publicado: (2022)

Correction: The Rationale for Using Rifabutin in the Treatment of MDR and XDR Tuberculosis Outbreaks
por: Sirgel, Frederick A., et al.
Publicado: (2015)

Low-dose amikacin in the treatment of Multidrug-resistant Tuberculosis (MDR-TB)
por: Sabur, Natasha F., et al.
Publicado: (2021)

Treatment of Complex Cutaneous Leishmaniasis with Liposomal Amphotericin B
por: Ubals, Maria, et al.
Publicado: (2021)

Impact of the COVID-19 pandemic on tuberculosis management in Spain
por: Aznar, M.L., et al.
Publicado: (2021)

Blood Stream Infections from MDR Bacteria
por: Di Franco, Sveva, et al.
Publicado: (2021)

Cost-effectiveness of bedaquiline in MDR and XDR tuberculosis in Italy
por: Codecasa, Luigi R., et al.
Publicado: (2017)

Predictors of Multidrug-Resistant Tuberculosis (MDR-TB) in Sudan
por: Ali, Monadil H., et al.
Publicado: (2019)

Early detection of MDR Mycobacterium tuberculosis mutations in Pakistan
por: Aftab, Ayma, et al.
Publicado: (2021)

Activity of Semi-Synthetic Mulinanes against MDR, Pre-XDR, and XDR Strains of Mycobacterium tuberculosis
por: Martínez-González, María Alejandrina, et al.
Publicado: (2021)

Adherence and Toxicity during the Treatment of Latent Tuberculous Infection in a Referral Center in Spain
por: Puyana Ortiz, Juan David, et al.
Publicado: (2023)

MDR Shigella sonnei in Spain: an ever-evolving emerging threat?
por: Ortiz de la Rosa, José Manuel, et al.
Publicado: (2022)

Genetic profiling of Mycobacterium tuberculosis revealed “modern” Beijing strains linked to MDR-TB from Southwestern Colombia
por: Nieto Ramirez, Luisa Maria, et al.
Publicado: (2020)

Risk of Trypanosoma cruzi infection among travellers visiting friends and relatives to continental Latin America
por: Sánchez-Montalvá, Adrián, et al.
Publicado: (2021)

Epidemiology of multidrug-resistant tuberculosis (MDR-TB) in Ethiopia: a systematic review and meta-analysis of the prevalence, determinants and treatment outcome
por: Girum, Tadele, et al.
Publicado: (2018)

Association of anti-tuberculosis drug concentrations in hair and treatment outcomes in MDR- and XDR-TB
por: Metcalfe, John, et al.
Publicado: (2019)

Beijing Lineage of MDR Mycobacterium tuberculosis in Bulgaria, 2007–2011
por: Panaiotov, Stefan, et al.
Publicado: (2014)

The Burden of MDR/XDR Tuberculosis in Coastal Plains Population of China
por: Yang, Xiujun, et al.
Publicado: (2015)

First insights on the genetic diversity of MDR Mycobacterium tuberculosis in Lebanon
por: Panossian, Balig, et al.
Publicado: (2018)

Analysing non-synonymous mutations in XDR and MDR tuberculosis drugs
por: Surana, Pallavi, et al.
Publicado: (2019)

First insights into the phylogenetic diversity of Mycobacterium tuberculosis in Kuwait and evaluation of REBA MTB-MDR assay for rapid detection of MDR-TB
por: Al-Mutairi, Noura M., et al.
Publicado: (2022)

MDR-TB treatment as prevention: The projected population-level impact of expanded treatment for multidrug-resistant tuberculosis
por: Kendall, Emily A., et al.
Publicado: (2017)

Simultaneous detection of Mycobacterium tuberculosis complex and resistance to Rifampicin and Isoniazid by MDR/MTB ELITe MGB(®) Kit for the diagnosis of tuberculosis
por: Bisognin, Francesco, et al.
Publicado: (2020)

Risk of SARS-CoV-2 Infection in Previously Infected and Non-Infected Cohorts of Health Workers at High Risk of Exposure
por: Sánchez-Montalvá, Adrián, et al.
Publicado: (2021)

Linkage of Presumptive Multidrug Resistant Tuberculosis (MDR-TB) Patients to Diagnostic and Treatment Services in Cambodia
por: Khann, Sokhan, et al.
Publicado: (2013)

Clinical characteristics and treatment outcomes of patients with MDR tuberculosis in Dar Es Salaam region, Tanzania
por: Myemba, David T, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_h4rt9d20feg0b40u90rb2vcsvr